Overall, our results point out to relevant consequences of TNFSF10 immunoneutralization in counteracting the inflammatory/immune-response sustained by miR-155 upregulation and consequent SOCS-1 downregulation in the AD retina. The gene discussed is SOCS1; the disease is Alzheimer disease.